Brown Brothers Harriman & CO Sanofi Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Sanofi stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 500 shares of SNY stock, worth $23,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 4,648 89.24%

Holding current value

$23,985

Previous $225,000 87.56%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$48.54 - $58.53 $201,343 - $242,782	-4,148 Reduced 89.24%	500 $28,000
Q2 2024 Aug 09, 2024	SELL	$45.39 - $50.36 $87,375 - $96,943	-1,925 Reduced 29.29%	4,648 $225,000
Q1 2024 May 10, 2024	BUY	$45.75 - $52.48 $21,914 - $25,137	479 Added 7.86%	6,573 $319,000
Q4 2023 Feb 12, 2024	SELL	$43.13 - $54.79 $41,663 - $52,927	-966 Reduced 13.68%	6,094 $303,000
Q3 2023 Nov 13, 2023	BUY	$50.95 - $55.2 $50,032 - $54,206	982 Added 16.16%	7,060 $378,000
Q2 2023 Aug 07, 2023	SELL	$50.45 - $57.18 $30,976 - $35,108	-614 Reduced 9.18%	6,078 $327,000
Q1 2023 May 11, 2023	BUY	$45.86 - $54.45 $28,158 - $33,432	614 Added 10.1%	6,692 $364,000
Q4 2022 Feb 09, 2023	SELL	$38.86 - $48.55 $39,637 - $49,521	-1,020 Reduced 14.37%	6,078 $294,000
Q3 2022 Nov 10, 2022	BUY	$37.22 - $100.5 $21,662 - $58,491	582 Added 8.93%	7,098 $270,000
Q2 2022 Aug 11, 2022	BUY	$48.99 - $57.46 $18,028 - $21,145	368 Added 5.99%	6,516 $326,000
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $267,464 - $295,987	5,517 Added 874.33%	6,148 $316,000
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $6,166 - $6,857	131 Added 26.2%	631 $32,000
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $58,779 - $65,309	-1,293 Reduced 72.11%	500 $25,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $51.62 $8,878 - $10,117	196 Added 12.27%	1,793 $87,000
Q3 2020 Nov 16, 2020	SELL	$49.47 - $53.77 $10,141 - $11,022	-205 Reduced 11.38%	1,597 $80,000
Q2 2020 Aug 13, 2020	BUY	$42.91 - $52.5 $49,818 - $60,952	1,161 Added 181.12%	1,802 $92,000
Q1 2020 May 15, 2020	SELL	$38.02 - $51.66 $46,460 - $63,128	-1,222 Reduced 65.59%	641 $28,000
Q4 2019 Feb 14, 2020	BUY	$44.25 - $50.86 $45,489 - $52,284	1,028 Added 123.11%	1,863 $94,000
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $310,416 - $358,894	-7,695 Reduced 90.21%	835 $39,000
Q2 2019 Aug 14, 2019	SELL	$40.43 - $44.3 $28,543 - $31,275	-706 Reduced 7.64%	8,530 $369,000
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $356,690 - $396,876	8,736 Added 1747.2%	9,236 $409,000
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $167,960 - $188,283	-4,199 Reduced 89.36%	500 $22,000
Q1 2018 May 14, 2018	BUY	$38.98 - $45.76 $163,677 - $192,146	4,199 Added 839.8%	4,699 $188,000
Q2 2017 Aug 14, 2017	BUY	N/A	500	500 $24,000

Others Institutions Holding SNY

# of Institutions

820

Shares Held

274M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Sanofi Transaction History